ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,738.52
-1.78%
US Tech 100
19,620.80
-2.29%
다우존스 지수
42,579.08
-0.99%
Bitcoin
88,006.51
-2.14%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. IGM Biosciences Inc (IGMS) 시세

IGM Biosciences Inc

IGM Biosciences Inc (IGMS)

NASDAQ
1.40
0.05
(3.70%)
마감 07 3월 6:00AM
15분 지연
1.40
0.00
(0.00%)
시간외 거래: 6:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
1.40
매수가
1.33
매도가
1.40
거래량
217,757
1.32 일간 변동폭 1.425
1.1874 52주 범위 22.50
market_cap
83.25M
전일 종가
1.35
개장가
1.335
최근 거래 시간
2
@
1.33
마지막 거래 시간
재정 규모
US$ 299,650
VWAP
1.3761
평균 볼륨(3m)
495,591
발행 주식
59,464,181
배당수익률
-
주가수익률
-0.34
주당순이익(EPS)
-4.14
매출
2.13M
순이익
-246.42M

IGM Biosciences Inc 정보

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.igmbio.com
본부
Dover, Delaware, USA
설립됨
-
IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker IGMS. The last closing price for IGM Biosciences was US$1.35. Over the last year, IGM Biosciences shares have traded in a share price range of US$ 1.1874 to US$ 22.50.

IGM Biosciences currently has 59,464,181 shares in issue. The market capitalisation of IGM Biosciences is US$80.28 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -0.34.

IGMS 최신 뉴스

추가 뉴스

Form 8-K/A - Current report: [Amend]
Edgar (US Regulatory)
6 시간 전
IGMS (3.70%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
6 시간 전
IGMS (3.70%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 1월 2025
IGMS (3.70%)

Form 8-K - Current report
Edgar (US Regulatory)
11 1월 2025
IGMS (3.70%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 1월 2025
IGMS (3.70%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 1월 2025
IGMS (3.70%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 1월 2025
IGMS (3.70%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 1월 2025
IGMS (3.70%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 12월 2024
IGMS (3.70%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.118.527131782951.291.41.18742192381.32171499CS
4-0.19-11.94968553461.591.621.18742492331.38164378CS
12-7.69-84.5984598469.099.51.18744955912.61084778CS
26-8.84-86.32812510.2422.51.18743837037.63303208CS
52-10.88-88.599348534212.2822.51.18743409008.43406896CS
156-14.31-91.08847867615.7135.981.187436774615.19502059CS
260-56.6-97.5862068966581331.187429780027.61441097CS

IGMS - Frequently Asked Questions (FAQ)

What is the current IGM Biosciences share price?
The current share price of IGM Biosciences is US$ 1.40
How many IGM Biosciences shares are in issue?
IGM Biosciences has 59,464,181 shares in issue
What is the market cap of IGM Biosciences?
The market capitalisation of IGM Biosciences is USD 80.28M
What is the 1 year trading range for IGM Biosciences share price?
IGM Biosciences has traded in the range of US$ 1.1874 to US$ 22.50 during the past year
What is the PE ratio of IGM Biosciences?
The price to earnings ratio of IGM Biosciences is -0.34
What is the cash to sales ratio of IGM Biosciences?
The cash to sales ratio of IGM Biosciences is 38.83
What is the reporting currency for IGM Biosciences?
IGM Biosciences reports financial results in USD
What is the latest annual turnover for IGM Biosciences?
The latest annual turnover of IGM Biosciences is USD 2.13M
What is the latest annual profit for IGM Biosciences?
The latest annual profit of IGM Biosciences is USD -246.42M
What is the registered address of IGM Biosciences?
The registered address for IGM Biosciences is CORPORATION TRUST CENTER, 1209 ORANGE ST, DOVER, DELAWARE, 19901
What is the IGM Biosciences website address?
The website address for IGM Biosciences is www.igmbio.com
Which industry sector does IGM Biosciences operate in?
IGM Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
359.59M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
694.71M
LZMHLZ Technology Holdings Ltd
US$ 9.79
(33.56%)
590.5k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 14.62
(33.39%)
16.07M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
135.24M
BLNEEastside Distilling Inc
US$ 0.7846
(-89.40%)
12.25k
ACONAclarion Inc
US$ 1.5501
(-77.86%)
51.53M
ELABPMGC Holdings Inc
US$ 0.7132
(-42.02%)
1.51M
SNBRSleep Number Corporation
US$ 7.49
(-41.89%)
4.56M
CCLDCareCloud Inc
US$ 2.0904
(-33.00%)
1.23M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
694.71M
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
359.59M
NVDANVIDIA Corporation
US$ 110.57
(-5.74%)
321.25M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
135.24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.75
(-11.38%)
134.95M

IGMS Discussion

게시물 보기
Monksdream Monksdream 8 월 전
IGMS under $10
👍️0
Monksdream Monksdream 10 월 전
IGMS under $10
👍️0
crudeoil24 crudeoil24 3 년 전
Truist Reiterates Buy Rating, $80 Price Target.
👍️0
crudeoil24 crudeoil24 3 년 전
Let's see if IGMS gets FDA phase I,II,III, approvals . Sanofi believes it'll happen.
👍️0
crudeoil24 crudeoil24 3 년 전
14M float!
👍️0
crudeoil24 crudeoil24 3 년 전
Tons of cash going forward > IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it intends to offer and sell $200.0 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, non-voting common stock, in an underwritten public offering. In addition, IGM intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares at the public offering price, less underwriting discounts and commissions. All of the securities offered in the offering will be sold by IGM. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
J.P. Morgan, BofA Securities, Stifel, and Guggenheim Securities are acting as joint book-running managers for the offering.
👍️0
TheFinalCD TheFinalCD 3 년 전
https://ih.advfn.com/stock-market/NASDAQ/igm-biosciences-IGMS/stock-news/87682546/igm-announces-proposed-public-offering

https://www.wsgr.com/print/v2/content/185066/Firm-Advises-IGM-Biosciences%2C-Inc.-on-%24230-Million-Public-Offering.pdf
👍️0

최근 히스토리

NASDAQ
IGMS
IGM Biosciences
LSE
BYOT
Byotrol
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지